Alterity Therapeutics (ATHE) Times Interest Earned (2019 - 2024)
Alterity Therapeutics (ATHE) posted quarterly Times Interest Earned of -$2279.8 for Q4 2019.
Alterity Therapeutics (ATHE) Times Interest Earned (2019 - 2024) Analysis & Trends
Alterity Therapeutics' Times Interest Earned history runs 1 years deep, the most recent figure standing at -$2279.8 for Q4 2019.
- In Q4 2019, Times Interest Earned changed N/A year-over-year to -$2279.8; the TTM figure through Dec 2019 stood at -$13540.9 (changed N/A YoY), while the FY2025 annual figure was -$1962.1, up 26.81% from the prior year.
- Times Interest Earned for Q4 2019 stood at -$2279.8.
- The five-year high for Times Interest Earned was -$2279.8 in Q4 2019, with the low at -$2279.8 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.75 Bn | 130.90 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.96 Bn | 77.96 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.33 Bn | 51.19 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.56 Bn | 28.25 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.32 Bn | 26.49 Bn | - | 1.42 |
| 10 | Alterity Therapeutics | 48.83 Mn | 16.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 2,682.97 |
| Jun 30, 2023 | 3,060.69 |
| Jun 30, 2022 | 5,698.97 |
| Dec 31, 2019 | -2,279.81 |